Kemp Dolliver
Stock Analyst at Brookline Capital
(0.27)
# 4,197
Out of 4,893 analysts
15
Total ratings
25%
Success rate
-29.34%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Initiates: Buy | $17 | $4.44 | +282.88% | 1 | Dec 5, 2024 | |
VRCA Verrica Pharmaceuticals | Downgrades: Hold | n/a | $0.82 | - | 2 | Oct 2, 2024 | |
IBIO iBio, Inc. | Initiates: Buy | $3.6 | $0.84 | +330.93% | 1 | Jul 22, 2024 | |
DARE Daré Bioscience | Upgrades: Buy | $36 | $2.44 | +1,375.41% | 2 | May 15, 2024 | |
OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $1.95 | +1,510.26% | 1 | Jan 25, 2024 | |
CYCC Cyclacel Pharmaceuticals | Downgrades: Hold | n/a | $3.73 | - | 1 | Dec 19, 2023 | |
LNTH Lantheus Holdings | Initiates: Buy | $100 | $83.49 | +19.77% | 1 | Nov 30, 2023 | |
EDSA Edesa Biotech | Maintains: Buy | $57 | $2.11 | +2,607.84% | 2 | Oct 12, 2023 | |
GNLX Genelux | Initiates: Hold | $25 | $3.46 | +622.54% | 1 | May 18, 2023 | |
ECOR electroCore | Initiates: Buy | $19 | $7.98 | +134.96% | 1 | Jan 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.69 | +1,062.12% | 1 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $1.06 | +433.02% | 1 | Feb 2, 2022 |
Y-mAbs Therapeutics
Dec 5, 2024
Initiates: Buy
Price Target: $17
Current: $4.44
Upside: +282.88%
Verrica Pharmaceuticals
Oct 2, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.82
Upside: -
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $0.84
Upside: +330.93%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $2.44
Upside: +1,375.41%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $1.95
Upside: +1,510.26%
Cyclacel Pharmaceuticals
Dec 19, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.73
Upside: -
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $83.49
Upside: +19.77%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $2.11
Upside: +2,607.84%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $3.46
Upside: +622.54%
electroCore
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $7.98
Upside: +134.96%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.69
Upside: +1,062.12%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $1.06
Upside: +433.02%